whether alpha blockers (Cardura, Hytrin, etc) are safe for treating hypertension
July 2001
A petition for the FDA to add a warning to Cardura is renewing the controversy about whether alpha blockers (Cardura, Hytrin, etc) are safe for treating hypertension.
This stems from the National Institutes of Health's huge ALLHAT hypertension trial.
It suggests that patients on Cardura are TWICE as likely to be hospitalized for heart failure as those on chlorthalidone.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive